Stockreport

GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEX®, (cannabidiol) oral solution, for the treatment of seizures ...

GW PHARMACEUTICALS PLC AMERICA  (GWPH) 
Last gw pharmaceuticals plc america earnings: 11/5 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gwpharm.com/investor-relations
PDF LONDON, March 13, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and co [Read more]